Content about Specialty Pharmacy

May 6, 2013
New Jersey attorney general's office releases anticrime best practices for pharmacy

Retail pharmacies, drug makers and law enforcement have a variety of methods used to fight organized crime, and the New Jersey Office of the Attorney General has drawn up a list of best practices that pharmacies can use to keep stores, drugs, staff and customers safe.

May 3, 2013
Study finds testicular cancer rates on the rise among males aged 15-34

Rates of testicular cancer among young men have risen significantly over the last two decades across racial and ethnic groups, according to a new study, and researchers are wondering what accounts for it.

May 1, 2013
Prasco to distribute authorized generic treatment for tumor disorder

Prasco Labs has signed a deal with WellSpring Pharmaceutical Corp. to market an authorized generic version of a drug for a rare tumor disorder.

May 1, 2013
Rite Aid signs on as platinum sponsor of EIF Revlon Run/Walk for Women

Rite Aid has signed on as a platinum sponsor of the Entertainment Industry Foundation Revlon Run/Walk for Women, the retail pharmacy chain said Wednesday.

April 30, 2013
Diplomat employees use coupons to collect food, toiletries for charity

Diplomat Specialty Pharmacy recently took "extreme couponing" to a new level, not to save money for customers, but to collect items for charity.

April 30, 2013
Drug for rare, fatal genetic disorder receives FDA approval

The Food and Drug Administration has approved a new treatment for a genetic disorder that affects about 500 people in the United States and 3,000 worldwide, the agency said Tuesday.

April 30, 2013
FDA approves anticoagulant-reversal product

The Food and Drug Administration has approved a drug that reverses the effects of anticoagulant drugs in patients who have suffered acute major bleeding, the agency said.

April 30, 2013
FDA approves Genentech arthritis drug for rare disorder in children

The Food and Drug Administration has approved a drug made by Genentech for a rare form of arthritis in children, the company said Tuesday.

April 30, 2013
FDA delays approval of Gilead HIV drugs

The Food and Drug Administration declined to approve two drugs for HIV made by Gilead Sciences for which the company was seeking approval for use as part of treatment regimens.

April 29, 2013
Duchenne muscular dystrophy group launches app

An organization focused on a fatal genetic disorder that affects men has launched a mobile app that allows for the location of clinical trials and clinics.

April 26, 2013
Mallinckrodt collects unused medications in St. Louis

Medical products manufacturer Covidien's pharmaceutical division is expanding an initiative to collect unused and unwanted medications.

April 26, 2013
NASP appoints Thomas Blissenbach to board of directors

Fairview Pharmacy Services director of business development Thomas Blissenbach has been appointed to the National Association of Specialty Pharmacy's board of directors, the NASP said.

April 26, 2013
Obama administration hopes to tackle prescription drug abuse

More than 1.3 million emergency room visits in 2010 were related to abuse of prescription drugs, and the problem has become widespread enough that the Centers for Disease Control and Prevention classifies it as an epidemic. In response, curbing abuse of prescription drugs has become a cornerstone of the Obama administration's drug policy.

April 26, 2013
PhRMA report lists 241 drugs under development for blood cancer

More than 200 drugs for blood cancers are under development, according to a new report by a drug industry trade group.

April 25, 2013
Avella provided more than $7 million in financial assistance to patients last year

Avella Specialty Pharmacy provided more than $7.2 million in financial assistance to patients last year, the company said Thursday.

April 25, 2013
Strengthening of drug supply chain's effects on independent pharmacies raises concerns

The House Committee on Energy and Commerce Subcommittee on Health heard testimony on Thursday morning from representatives of the Food and Drug Administration and several industry trade groups following the introduction of draft legislation that sponsors said would strengthen the country's pharmaceutical supply chain.

April 24, 2013
FDA approves drug for opioid-induced constipation

The Food and Drug Administration has approved a new drug for constipation related to use of opioid painkillers made by Sucampo Pharmaceuticals and Takeda Pharmaceuticals, the drug makers said.

April 24, 2013
Hospira looks to U.S. as it marks European biosimilar milestone

Generic drug maker Hospira marked its fifth year marketing knock-off versions of biotech drugs in Europe Wednesday as it presented at the 2013 Biotechnology Industry Organization International Convention this week.

April 24, 2013
Parents often complicit in teens' prescription drug abuse, study finds

A dramatic jump in the rates of misuse of prescription stimulants over the past four years is linked to lax attitudes on the part of parents, according to a new study, though misuse and abuse of prescription opioids has remained flat.

April 19, 2013
Diplomat Specialty Pharmacy CEO joins Flint, Mich., job-creation effort

Diplomat Specialty Pharmacy is among several Flint, Mich.-area companies that have signed on to a council to support a local business that makes scrubs and is interested in expanding beyond traditional markets.

April 18, 2013
Diplomat Specialty Pharmacy supports employee health and wellness with new programs

Diplomat Specialty Pharmacy has several new programs in the works to promote health and wellness among its employees, the company said.

April 18, 2013
Hospira announces new executive appointment

Generic drug maker Hospira has appointed Matt Stober as its SVP operations, the company said.

April 17, 2013
Hearing focuses on FDA response to meningitis outbreak

Food and Drug Administration commissioner Margaret Hamburg faced strong criticism Tuesday in a hearing before the House Committee on Energy and Commerce to investigate the nationwide outbreak of fungal meningitis linked to a Massachusetts compounding pharmacy, but she conceded the agency could have done more.

April 16, 2013
Authorities worry about abuse potential as OxyContin patent expires

Purdue Pharma's patent for OxyContin expired Tuesday, opening up the opioid painkiller to generic competition, but authorities have raised concerns about what they call the potential for generic versions to be abused.

April 16, 2013
FDA approves new labeling for OxyContin

The Food and Drug Administration will not approve generic versions of Purdue Pharma's painkiller OxyContin based on earlier versions of the drug that did not include features to thwart abuse, the agency said.

© 2013 Drug Store News. All Rights Reserved.